» Articles » PMID: 35272746

Molecular Epidemiology of the SARS-CoV-2 Variant Omicron BA.2 Sub-lineage in Denmark, 29 November 2021 to 2 January 2022

Abstract

Following emergence of the SARS-CoV-2 variant Omicron in November 2021, the dominant BA.1 sub-lineage was replaced by the BA.2 sub-lineage in Denmark. We analysed the first 2,623 BA.2 cases from 29 November 2021 to 2 January 2022. No epidemiological or clinical differences were found between individuals infected with BA.1 versus BA.2. Phylogenetic analyses showed a geographic east-to-west transmission of BA.2 from the Capital Region with clusters expanding after the Christmas holidays. Mutational analysis shows distinct differences between BA.1 and BA.2.

Citing Articles

SARS-CoV-2 introductions to the island of Ireland: a phylogenetic and geospatiotemporal study of infection dynamics.

Rice A, Troendle E, Bridgett S, Firoozi Nejad B, McKinley J, Bradley D Genome Med. 2024; 16(1):150.

PMID: 39702217 PMC: 11658175. DOI: 10.1186/s13073-024-01409-1.


Evolution of illness severity in hospital admissions due to COVID-19, Québec, Canada, January to April 2022.

Lo E, Fortin E, Gilca R, Trepanier P, Geagea H, Zhou Z Can Commun Dis Rep. 2024; 50(1-2):63-76.

PMID: 38655241 PMC: 11037885. DOI: 10.14745/ccdr.v50i12a08.


Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor.

Sultana N, Nagesha S, Lakshminarayana Reddy C, Ramesh B, Shyamalamma S, Shashidhara K Virol J. 2024; 21(1):88.

PMID: 38641844 PMC: 11031966. DOI: 10.1186/s12985-024-02365-3.


Clinical Manifestations of Infections with the Omicron Sub-Lineages BA.1, BA.2, and BA.5: A Retrospective Follow-Up Analysis of Public Health Data from Mecklenburg-Western Pomerania, Germany.

Goller K, Ziemann J, Kohler C, Becker K, Hubner N, The CoMV-Gen Study Group Viruses. 2024; 16(3).

PMID: 38543819 PMC: 10974208. DOI: 10.3390/v16030454.


Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants.

Ghildiyal T, Rai N, Rawat J, Singh M, Anand J, Pant G J Immunol Res. 2024; 2024:9125398.

PMID: 38304142 PMC: 10834093. DOI: 10.1155/2024/9125398.


References
1.
Veneti L, Boas H, Kristoffersen A, Stalcrantz J, Bragstad K, Hungnes O . Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022. Euro Surveill. 2022; 27(4). PMC: 8796289. DOI: 10.2807/1560-7917.ES.2022.27.4.2200077. View

2.
Ishikawa S, Zhukova A, Iwasaki W, Gascuel O . A Fast Likelihood Method to Reconstruct and Visualize Ancestral Scenarios. Mol Biol Evol. 2019; 36(9):2069-2085. PMC: 6735705. DOI: 10.1093/molbev/msz131. View

3.
Tian W, Li D, Zhang N, Bai G, Yuan K, Xiao H . O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an "O-Follow-N" rule. Cell Res. 2021; 31(10):1123-1125. PMC: 8326647. DOI: 10.1038/s41422-021-00545-2. View

4.
Brandal L, MacDonald E, Veneti L, Ravlo T, Lange H, Naseer U . Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Euro Surveill. 2021; 26(50). PMC: 8728491. DOI: 10.2807/1560-7917.ES.2021.26.50.2101147. View

5.
Espenhain L, Funk T, Overvad M, Edslev S, Fonager J, Ingham A . Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021. Euro Surveill. 2021; 26(50). PMC: 8728489. DOI: 10.2807/1560-7917.ES.2021.26.50.2101146. View